Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis

Huijbers, M.G.; Plomp, J.J.; Es, I.E. van; Fillie-Grijpma, Y.E.; Kamar-Al Majidi, S.; Ulrichts, P.; ... ; Verschuuren, J.J. (2019)

Article / Letter to editor

• MuSK
• Myasthenia gravis
• Neonatal Fc receptor
• Neuroimmunology
• Neuromuscular junction
• Neuromuscular diseases

• All authors: Huijbers, M.G.; Plomp, J.J.; Es, I.E. van; Fillie-Grijpma, Y.E.; Kamar-Al Majidi, S.; Ulrichts, P.; Haard, H. de; Hofman, E.; Maarel, S.M. van der; Verschuuren, J.J.
• Date: 2019-07-31
• Journal: Experimental Neurology
• Volume: 317
• Pages: 133 - 143
• DOI: doi:10.1016/j.expneurol.2019.03.001